By stimulating GLP-1 receptors, Wegovy helps to slow down digestion, reduce hunger, and increase feelings of fullness after meals
Primary Phase 3 readouts from the TRIUMPH program are currently ongoing
Its anxiolytic potential operates through a completely different pathway: the reduction of systemic inflammation that drives neuroinflammation and, consequently, anxiety
Mazdutide may become an alternative if tirzepatide is not tolerated, not effective, or not covered by insurance, but only once it receives regulatory approval
While some studies suggest that carnitine may not significantly improve athletic performance, the side effects of L-carnitine, particularly the cardiovascular risks, warrant caution
Stomach motility that is slowed by a GLP-1 drug will typically return to normal once the individual stops taking the drug